HK1176074A1 - 利用 和/或 源作為疫苗或用作診斷寄生蟲疾病 - Google Patents

利用 和/或 源作為疫苗或用作診斷寄生蟲疾病

Info

Publication number
HK1176074A1
HK1176074A1 HK13102882.2A HK13102882A HK1176074A1 HK 1176074 A1 HK1176074 A1 HK 1176074A1 HK 13102882 A HK13102882 A HK 13102882A HK 1176074 A1 HK1176074 A1 HK 1176074A1
Authority
HK
Hong Kong
Prior art keywords
vaccine
diagnostic
source
parasitic disease
parasitic
Prior art date
Application number
HK13102882.2A
Other languages
English (en)
Inventor
Alonso Bedate Carlos
Soto Alvarez Manuel
Original Assignee
Laboratorios Leti S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Leti S L filed Critical Laboratorios Leti S L
Publication of HK1176074A1 publication Critical patent/HK1176074A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
HK13102882.2A 2009-11-13 2013-03-07 利用 和/或 源作為疫苗或用作診斷寄生蟲疾病 HK1176074A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26102009P 2009-11-13 2009-11-13
EP09175929 2009-11-13
PCT/EP2010/067380 WO2011058137A1 (en) 2009-11-13 2010-11-12 The use of an l3 and/or l5 source as a vaccine or as a diagnostic for a parasitic disease

Publications (1)

Publication Number Publication Date
HK1176074A1 true HK1176074A1 (zh) 2013-07-19

Family

ID=42060726

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13102882.2A HK1176074A1 (zh) 2009-11-13 2013-03-07 利用 和/或 源作為疫苗或用作診斷寄生蟲疾病

Country Status (26)

Country Link
US (1) US10604551B2 (zh)
EP (2) EP3101028A1 (zh)
JP (1) JP5875987B2 (zh)
KR (1) KR101881947B1 (zh)
CN (2) CN107551264B (zh)
AP (1) AP3464A (zh)
AR (1) AR080621A1 (zh)
AU (1) AU2010317962B2 (zh)
BR (1) BR112012011395B1 (zh)
CA (1) CA2780740C (zh)
CO (1) CO6551684A2 (zh)
CY (1) CY1118402T1 (zh)
EA (1) EA022221B1 (zh)
EC (1) ECSP12011951A (zh)
ES (1) ES2612786T3 (zh)
HK (1) HK1176074A1 (zh)
HR (1) HRP20170176T1 (zh)
IL (1) IL219770A (zh)
MA (1) MA33813B1 (zh)
MX (1) MX341066B (zh)
PE (1) PE20121553A1 (zh)
PT (1) PT2499158T (zh)
SA (1) SA110310855B1 (zh)
TN (1) TN2012000217A1 (zh)
WO (1) WO2011058137A1 (zh)
ZA (1) ZA201203516B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA110310855B1 (ar) 2009-11-13 2014-09-16 Laboratories Leti S L Unipersonal استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي
CN103270048B (zh) * 2010-11-10 2016-11-23 热体实验室有限公司 新型佐剂
CN103796675B (zh) * 2011-05-09 2019-05-14 热体实验室有限公司 用于治疗炎症性疾病的分子
ES2681227T3 (es) * 2013-07-02 2018-09-12 Institut De Recherche Pour Le Développement Péptidos y métodos para la detección de la leishmaniasis
US10973897B2 (en) * 2016-04-14 2021-04-13 Peptcell Limited Chagas antigens and antibodies and compositions, methods and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5359681A (en) 1993-01-11 1994-10-25 University Of Washington Fiber optic sensor and methods and apparatus relating thereto
EP0893507A1 (en) 1997-07-25 1999-01-27 Institut Gustave Roussy Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment
ES2201551T3 (es) 1997-09-05 2004-03-16 Glaxosmithkline Biologicals S.A. Emulsiones de aceite en agua que contienen saponinas.
DK1141305T3 (da) 1998-12-23 2006-09-25 Leti Lab Kimært gen som koder for de antigene determinanter af fire proteiner af L. infantum
FR2826018B1 (fr) * 2001-06-18 2005-01-07 Pasteur Institut Tunis Gene associe a la virulence du parasite leishmania
EP1450821A1 (en) 2001-12-07 2004-09-01 Intercell AG Immunostimulatory oligodeoxynucleotides
AU2004232485B2 (en) 2003-04-23 2009-11-26 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Tuberculosis vaccine with improved efficacy
KR100992646B1 (ko) 2003-07-09 2010-11-05 제이에스알 가부시끼가이샤 파장판
PT1687023E (pt) 2003-11-05 2013-01-23 Leti Sl Lab Uso de histonas específicas para o tratamento de doenças parasitárias
CA2540736A1 (en) * 2005-04-08 2006-10-08 Institut Pasteur Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof
CN101466831A (zh) * 2006-04-10 2009-06-24 传染病研究所有限公司 用于诊断和治疗利什曼病的化合物和方法
US8916168B2 (en) * 2007-07-13 2014-12-23 Infectious Disease Research Institute Leishmania sterol 24-c-methyltransferase compositions for the prevention, treatment and diagnosis of leishmaniasis
CA2712475A1 (en) 2008-01-18 2009-07-23 Laboratorios Leti, S.L. Unipersonal Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant
US8969019B2 (en) * 2009-07-13 2015-03-03 Laboratorios Leti, S.L. Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (RPE)
SA110310855B1 (ar) 2009-11-13 2014-09-16 Laboratories Leti S L Unipersonal استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي

Also Published As

Publication number Publication date
ZA201203516B (en) 2013-01-31
IL219770A (en) 2017-10-31
AU2010317962A1 (en) 2012-06-21
KR101881947B1 (ko) 2018-07-26
AU2010317962B2 (en) 2014-09-18
CA2780740C (en) 2019-08-20
CN107551264A (zh) 2018-01-09
CN102712684A (zh) 2012-10-03
HRP20170176T1 (hr) 2017-04-07
SA110310855B1 (ar) 2014-09-16
WO2011058137A1 (en) 2011-05-19
EP3101028A1 (en) 2016-12-07
JP5875987B2 (ja) 2016-03-02
EA022221B1 (ru) 2015-11-30
CO6551684A2 (es) 2012-10-31
EA201290319A1 (ru) 2012-12-28
BR112012011395A2 (pt) 2020-09-01
TN2012000217A1 (en) 2013-12-12
EP2499158A1 (en) 2012-09-19
EP2499158B1 (en) 2016-11-02
MA33813B1 (fr) 2012-12-03
MX341066B (es) 2016-08-05
AR080621A1 (es) 2012-04-25
ES2612786T3 (es) 2017-05-18
JP2013510823A (ja) 2013-03-28
MX2012005522A (es) 2012-09-28
CA2780740A1 (en) 2011-05-19
AP3464A (en) 2015-11-30
CY1118402T1 (el) 2017-06-28
US20120263746A1 (en) 2012-10-18
ECSP12011951A (es) 2012-07-31
IL219770A0 (en) 2012-07-31
PE20121553A1 (es) 2012-12-13
CN107551264B (zh) 2021-05-11
AP2012006275A0 (en) 2012-06-30
US10604551B2 (en) 2020-03-31
KR20120104567A (ko) 2012-09-21
BR112012011395B1 (pt) 2022-03-03
PT2499158T (pt) 2017-01-24

Similar Documents

Publication Publication Date Title
PL3653150T3 (pl) Narzędzia chirurgiczne ultradźwiękowe
EP2691036A4 (en) SURGICAL ULTRASOUND INSTRUMENTS
EP2691037A4 (en) ULTRASONIC SURGICAL INSTRUMENTS
DK2462893T3 (da) Universel scanningsdel til anvendelse på dentalimplantat og dentalimplantat-analoge
PL2393426T3 (pl) Narzędzie chirurgiczne nadające się do sterylizowania
BR112012001637A2 (pt) dispositivo médico implantável
EP2473162A4 (en) MEDICAL DEVICE WITH EXTENDED USE
DK2658435T3 (da) Integreret dobbelt swept kilde til medicinsk oct afbildning
AP2014007420A0 (en) Integrated portable medical diagnostic system
GB2479176B (en) Surgical instrument
HRP20170176T1 (hr) Uporaba i3 i/ili l5 izvora kao cjepiva ili kao dijagnostičkog sredstva za parazitarnu bolest
BR112012003844A2 (pt) vacinas de pttv e diagnóstico
EP2542163A4 (en) SURGICAL INSTRUMENT
EP2564796A4 (en) MEDICAL INSTRUMENT
EP2464383A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF FLU
EP2495563A4 (en) DIAGNOSTIC AGENT FOR INFECTIOUS DISEASES
EP2691034A4 (en) ULTRASONIC SURGICAL INSTRUMENTS
EP2509526A4 (en) MULTIFIBRE FLEXIBLE SURGICAL PROBE
IT1396812B1 (it) Dispositivo per il trasporto di strumenti medicali.
GB0911643D0 (en) Surgical instrument
GB2469839B (en) Medical instrument
GB0908425D0 (en) Medical use
GB0905594D0 (en) Surgical instrument
BR112014006593A2 (pt) dispositivo médico para inserção no corpo humano
GB201016461D0 (en) Medical instrument